Business Wire
BusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex Times
Back to front
Apple iPhone “duo” valuation talk jumps, with focus on what Nov. 2 could reveal
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 22, 5:14 PM EDT

Apple iPhone “duo” valuation talk jumps, with focus on what Nov. 2 could reveal

A market note circulating on Yahoo Finance says analysts lifted an “iPhone duo” target price by about 44% and frames Nov. 2 as a key date for investors seeking clarity on the outlook.

Apple’s stock discussion on Tuesday centered less on company headlines and more on a recalibration of expectations tied to an “iPhone duo” scenario, according to a market note syndicated on Yahoo Finance.

The post, published as a market-news piece, argues that an updated target implies upside for AAPL holders and highlights a particular near-term catalyst date. It frames the move as a significant revision, saying the target was raised by roughly 44%, and points readers to what it says Nov. 2 may show.

In its summary of valuation levels, the note cites a current share price of $343.99 and presents a “mid” target price of approximately $485. It also references a separate street target of about $328, positioning the raised figure as more optimistic than the broader consensus referenced in the piece.

The same market note translates the gap between its current price and its target into an estimated potential total return of about 41%. It also expresses the implied pace of returns as an annualized internal rate of return of roughly 9% per year, a metric used by some analysts to restate expected performance into a single comparable yearly rate.

Beyond the target math, the post’s central message is timing. By emphasizing Nov. 2, it suggests investors are watching for some combination of new information, such as disclosures, guidance, or market reactions that could validate or undercut the revised assumptions behind the valuation range.

Apple-specific context matters here because iPhone demand and launch expectations continue to drive much of the company’s near-term sentiment. When analysts adjust forward expectations for iPhone mix, upgrade cycles, or the shape of new product demand, the effect often shows up quickly in target price models, even when the company itself has not issued a same-day update.

Still, there are limits to what the post itself discloses. The market note does not lay out, in the information provided with the syndicated excerpt, the detailed assumptions behind the 44% increase, nor does it specify what exactly is scheduled for Nov. 2 (such as an earnings release, a product event, or another form of company communication). That means investors and editors should treat the date as a signpost rather than a confirmed Apple calendar item based on the excerpt alone.

For what to watch next, the practical focus is whether Apple provides or implies new guidance that affects iPhone revenue expectations, gross margin assumptions, or product demand timing. If Nov. 2 coincides with additional clarity, analysts’ iPhone-related valuation work could be either reinforced or revised again quickly in follow-on notes. If it does not, the “iPhone duo” framing may remain speculative and continue to drive volatility mainly through expectations rather than concrete new company data.

Why It Matters

  • Target price revisions can quickly influence sentiment for Apple shares, particularly when linked to iPhone demand assumptions.
  • The emphasis on Nov. 2 indicates that investors may be positioning ahead of a near-term catalyst, even if the excerpt does not specify the exact nature of the event.
  • Differences between an individual note’s target and the “street” target can indicate changing expectations for growth, margins, or upgrade cycles.
  • Because the excerpt does not detail model inputs, the market’s response may depend on whether upcoming information confirms the assumptions behind the raised target.

Sources

Key Facts

  • A market note published via Yahoo Finance says an “iPhone duo” target price was raised by about 44%.
  • The note cites a current AAPL price of $343.99 and a “mid” target of about $485.
  • The same excerpt references a “street target” of about $328 for comparison.
  • The post estimates potential total return of about 41% and an annualized internal rate of return of roughly 9% per year.
  • The note highlights Nov. 2 as a key date for what investors may look for next.

Technology Related